Sword Bio is a leading bioanalytical CRO supporting biotech and pharmaceutical companies with research-grade assays, GLP pre-clinical and clinical assay development, validation, and sample analysis. We assist clients with PK, biomarkers, and various types of immunogenicity assays for a variety of therapeutic and disease states.
Sword’s team is comprised of industry-experienced science and QA experts ensuring the highest levels of science, data integrity, and regulatory compliance through all phases of clinical development.

Sword has built an innovative excess capacity model that offers its partners no lead times for new programs, transparency, communication, and white-glove service so that our clients can quickly achieve their goals.